论文部分内容阅读
为探讨肺心病呼吸衰竭与中分子物质的关系,我们对46例肺心病患者进行了89例次中分子物质(MMS)含量动态鉴测,同时进行血气鉴测,以观察MMS在肺心病呼衰时含量变化及其临床意义。对象与方法:46例病人,均符合1977年全国肺心病诊断标准,以PaO_2<6.7kPa为呼衰组,51例正常对照组均无急慢性呼吸系统疾病,肝肾功能均正常。采用第一军医大学改进的Faбриsлян氏紫外吸收法测定血浆MMS含量,同步取桡动脉血做血气分析,统计方法使用配对资料的t检验及多元
In order to explore the relationship between pulmonary heart disease respiratory failure and molecular substances, we performed dynamic detection of 89 cases of sub-molecular substance (MMS) in 46 patients with pulmonary heart disease, and blood gas detection at the same time to observe the MMS in respiratory failure of pulmonary heart disease Changes in content and clinical significance. Subjects and Methods: All the 46 patients were in accordance with the diagnostic criteria of pulmonary heart disease in 1977. PaO2 <6.7 kPa was used as the group of respiratory failure. There were no acute and chronic respiratory diseases in 51 normal controls, and liver and kidney function were normal. The plasma concentration of MMS was measured by the improved method of Faбриsля 氏 ultraviolet absorption of the First Military Medical University. Blood samples were taken from the radial artery simultaneously. The t-test and multivariate statistical methods were used for the statistical methods.